⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14996956 | 0.79 | — | — | |
| SCHEMBL2307623 | 0.72 | — | — | |
| SCHEMBL1178421 | 0.70 | — | — | |
| SCHEMBL2823555 | 0.67 | — | — | |
| SCHEMBL3493349 | 0.66 | — | — | |
| SCHEMBL11031795 | 0.60 | EPAS1 (0.35) | — | |
| SCHEMBL9571787 | 0.60 | — | — | |
| SCHEMBL4724120 | 0.60 | — | — | |
| SCHEMBL1724424 | 0.58 | — | — | |
| SCHEMBL19610209 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230096602-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR TREATMENT OF RENAL DISEASE | EIRGEN PHARMA LTD. (IE) | 2023-03-30 | — | — | US | claimed |
| EP-4096660-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR THE TREATMENT OF RENAL DISEASE | EirGen Pharma Ltd. (IE) | 2022-12-07 | — | — | EP | claimed |
| CN-115023225-A | Tetrahydrocyclopenta [ B ] indole compounds for the treatment of renal diseases | 伊尔根制药有限公司 | 2022-09-06 | — | — | CN | claimed |
| WO-2021151905-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR THE TREATMENT OF RENAL DISEASE | TRANSITION THERAPEUTICS (IRELAND 2) LIMITED (IE) | 2021-08-05 | — | — | WO | claimed |
| EP-3541377-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BPH | Transition Therapeutics (Ireland 2) Limited (IE) | 2019-09-25 | — | — | EP | claimed |
| EP-2968271-B1 | INDOLE AND CARBAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS MRSA SENSITIVE ANTIBIOTICS | MARTIN LUTHER UNIV HALLE WITTENBERG (DE) | 2019-01-09 | — | — | EP | claimed |
| US-20180185347-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BHP | TRANSITION THERAPEUTICS (IRELAND 2) LIMITED (IE) | 2018-07-05 | — | — | US | claimed |
| WO-2018092045-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS AND PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF THE SIGNS AND SYMPTOMS OF BPH | TRANSITION THERAPEUTICS (IRELAND 2) LIMITED (IE) | 2018-05-24 | — | — | WO | claimed |
| EP-2968271-A1 | DERIVATIVES OF INDOLES AND CARBAZOLES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS MRSA-SENSITIVE ANTIBIOTICS | Martin-Luther-Universität Halle-Wittenberg (DE) | 2016-01-20 | — | — | EP | claimed |
| WO-2014139512-A1 | DERIVATIVES OF INDOLES AND CARBAZOLES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS MRSA-SENSITIVE ANTIBIOTICS | Martin-Luther-Universität Halle-Wittenberg (DE) | 2014-09-18 | — | — | WO | claimed |
| JP-6321898-A | — | — | None | — | — | JP | disclosed |
| US-20230096602-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR TREATMENT OF RENAL DISEASE | EIRGEN PHARMA LTD. (IE) | 2023-03-30 | — | — | US | disclosed |
| US-20230096602-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR TREATMENT OF RENAL DISEASE | EIRGEN PHARMA LTD. (IE) | 2023-03-30 | — | — | US | disclosed |
| EP-4096660-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR THE TREATMENT OF RENAL DISEASE | EirGen Pharma Ltd. (IE) | 2022-12-07 | — | — | EP | disclosed |
| EP-4096660-A1 | TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR THE TREATMENT OF RENAL DISEASE | EirGen Pharma Ltd. (IE) | 2022-12-07 | — | — | EP | disclosed |
| EP-0614888-B1 | Tetrahydrocyclopent[b]indole methanamines and related compounds, a process for their preparation and their use as medicaments | HOECHST MARION ROUSSEL INC (US) | 1997-05-07 | — | — | EP | disclosed |
| EP-0614888-B1 | Tetrahydrocyclopent[b]indole methanamines and related compounds, a process for their preparation and their use as medicaments | HOECHST MARION ROUSSEL INC (US) | 1997-05-07 | — | — | EP | disclosed |
| JP-H06321898-A | TETRAHYDROCYCLOPENT(B)INDOLE METHANAMINES AND RELATED COMPOUND, PROCESS FOR PREPARATION THEREFOR AND USE THEREOF AS DRUG | HOECHST ROUSSEL PHARMACEUT INC | 1994-11-22 | — | — | JP | disclosed |
| US-5350762-A | Alzheimer's | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1994-09-27 | — | — | US | disclosed |
| EP-0614888-A1 | Tetrahydrocyclopent[b]indole methanamines and related compounds, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1994-09-14 | — | — | EP | disclosed |